Response to Yehia et al.

Por Siraj, Abdul K., Masoodi, Tariq, Alkuraya, Fowzan S., Al-Kuraya, Khawla S.
Publicado no Am J Hum Genet (2017)

Single Monochrome Real-Time RT-PCR Assay for Identification, Quantification, and Breakpoint Cluster Region Determination of t(9;22) Transcripts

Por Gutiérrez, Marina I., Timson, Georgina, Siraj, Abdul K., Bu, Rong, Barbhaya, Shakuntala, Banavali, Sripad, Bhatia, Kishor
Publicado em 2005

Role of leptin and its receptors in the pathogenesis of thyroid cancer

Por Uddin, Shahab, Hussain, Azhar R, Siraj, Abdul K, Khan, Omar S, Bavi, Prashant P, Al-Kuraya, Khawla S
Publicado em 2011

Dual Targeting of mTOR Activity with Torin2 Potentiates Anticancer Effects of Cisplatin in Epithelial Ovarian Cancer

Por Hussain, Azhar R, Al-Romaizan, Maha, Ahmed, Maqbool, Thangavel, Saravanan, Al-Dayel, Fouad, Beg, Shaham, Uddin, Shahab, Siraj, Abdul K, Al-Kuraya, Khawla S
Publicado no Mol Med (2015)

Genomic Profiling of Thyroid Cancer Reveals a Role for Thyroglobulin in Metastasis

Por Siraj, Abdul K., Masoodi, Tariq, Bu, Rong, Beg, Shaham, Al-Sobhi, Saif S., Al-Dayel, Fouad, Al-Dawish, Mohammed, Alkuraya, Fowzan S., Al-Kuraya, Khawla S.
Publicado no Am J Hum Genet (2016)

ALK alteration is a frequent event in aggressive breast cancers

Por Siraj, Abdul K., Beg, Shaham, Jehan, Zeenath, Prabhakaran, Sarita, Ahmed, Maqbool, R.Hussain, Azhar, Al-Dayel, Fouad, Tulbah, Asma, Ajarim, Dahish, Al-Kuraya, Khawla S.
Publicado no Breast Cancer Res (2015)

Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells

Por Ahmed, Maqbool, Hussain, Azhar R, Siraj, Abdul K., Uddin, Shahab, Al-Sanea, Nasser, Al-Dayel, Fouad, Al-Assiri, Mohammed, Beg, Shaham, Al-Kuraya, Khawla S.
Publicado no Mol Cancer (2015)

Identification of novel BRCA founder mutations in Middle Eastern breast cancer patients using capture and Sanger sequencing analysis

Por Bu, Rong, Siraj, Abdul K., Al‐Obaisi, Khadija A.S., Beg, Shaham, Al Hazmi, Mohsen, Ajarim, Dahish, Tulbah, Asma, Al‐Dayel, Fouad, Al‐Kuraya, Khawla S.
Publicado no Int J Cancer (2016)

Clinico-pathological significance of TNF alpha-induced protein3 (TNFAIP3) in Middle Eastern colorectal carcinoma

Por Bavi, Prashant, Abubaker, Jehad, Al-Sanea, Nasser, Abduljabbar, Alaa, Ashari, Luai H., Alhomoud, Samar, Al-Dayel, Fouad, Uddin, Shahab, Siraj, Abdul K., Al-Kuraya, Khawla S.
Publicado em 2011

Polymorphisms of selected Xenobiotic Genes contribute to the development of Papillary Thyroid Cancer susceptibility in Middle Eastern population

Por Siraj, Abdul K, Ibrahim, Muna, Al-Rasheed, Maha, Abubaker, Jehad, Bu, Rong, Siddiqui, Shakaib U, Al-Dayel, Fouad, Al-Sanea, Osama, Al-Nuaim, Abdulrahman, Uddin, Shahab, Al-Kuraya, Khawla
Publicado em 2008

Genome-Wide Expression Analysis of Middle Eastern Colorectal Cancer Reveals FOXM1 as a Novel Target for Cancer Therapy

Por Uddin, Shahab, Ahmed, Maqbool, Hussain, Azhar, Abubaker, Jehad, Al-Sanea, Nasser, AbdulJabbar, Alaa, Ashari, Luai H., Alhomoud, Samar, Al-Dayel, Fouad, Jehan, Zeenath, Bavi, Prashant, Siraj, Abdul K., Al-Kuraya, Khawla S.
Publicado em 2011

A very low incidence of BRAF mutations in Middle Eastern colorectal carcinoma

Por Siraj, Abdul K, Bu, Rong, Prabhakaran, Sarita, Bavi, Prashant, Beg, Shaham, Al Hazmi, Mohsen, Al-Rasheed, Maha, Alobaisi, Khadija, Al-Dayel, Fouad, AlManea, Hadeel, Al-Sanea, Nasser, Uddin, Shahab, Al-Kuraya, Khawla S
Publicado em 2014

HER2, TOP2A, CCND1, EGFR and C‐MYC oncogene amplification in colorectal cancer

Por Al‐Kuraya, Khawla, Novotny, Hedvika, Bavi, Prashant, Siraj, Abdul K, Uddin, Shahab, Ezzat, Adnan, Sanea, Nasser Al, Al‐Dayel, Fouad, Al‐Mana, Hadeel, Sheikh, Salwa S, Mirlacher, Martina, Tapia, Coya, Simon, Ronald, Sauter, Guido, Terracciano, Luigi, Tornillo, Luigi
Publicado em 2007